Share-based Payment Arrangement, Expense of EXACT SCIENCES CORP from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
EXACT SCIENCES CORP quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • EXACT SCIENCES CORP Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $51,600,000, a 5.7% increase year-over-year.
  • EXACT SCIENCES CORP Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $211,085,000, a 5.9% decline year-over-year.
  • EXACT SCIENCES CORP annual Share-based Payment Arrangement, Expense for 2024 was $214,885,000, a 7.1% decline from 2023.
  • EXACT SCIENCES CORP annual Share-based Payment Arrangement, Expense for 2023 was $231,312,000, a 12% increase from 2022.
  • EXACT SCIENCES CORP annual Share-based Payment Arrangement, Expense for 2022 was $206,823,000, a 39% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

EXACT SCIENCES CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $211,085,000 $51,600,000 +$2,800,000 +5.7% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $208,285,000 $55,800,000 -$800,000 -1.4% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $209,085,000 $54,600,000 -$5,800,000 -9.6% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $214,885,000 $49,085,000 -$9,492,000 -16% 01 Oct 2024 31 Dec 2024 10-K 19 Feb 2025 2024 FY
Q3 2024 $224,377,000 $48,800,000 -$13,071,000 -21% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $237,448,000 $56,600,000 -$5,125,000 -8.3% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $242,573,000 $60,400,000 +$11,261,000 +23% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $231,312,000 $58,577,000 +$12,554,000 +27% 01 Oct 2023 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 $218,758,000 $61,871,000 +$12,371,000 +25% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $206,387,000 $61,725,000 +$2,825,000 +4.8% 01 Apr 2023 30 Jun 2023 10-Q 05 Nov 2024 2024 Q3
Q1 2023 $203,562,000 $49,139,000 -$3,261,000 -6.2% 01 Jan 2023 31 Mar 2023 10-Q 05 Nov 2024 2024 Q3
Q4 2022 $206,823,000 $46,023,000 -$9,803,000 -18% 01 Oct 2022 31 Dec 2022 10-K 19 Feb 2025 2024 FY
Q3 2022 $216,626,000 $49,500,000 -$14,100,000 -22% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q1
Q2 2022 $230,726,000 $58,900,000 +$2,600,000 +4.6% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q1
Q1 2022 $228,126,000 $52,400,000 -$111,100,000 -68% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $339,226,000 $55,826,000 +$14,020,000 +34% 01 Oct 2021 31 Dec 2021 10-K 21 Feb 2024 2023 FY
Q3 2021 $325,206,000 $63,600,000 +$22,100,000 +53% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $303,106,000 $56,300,000 +$16,300,000 +41% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $286,806,000 $163,500,000 +$133,900,000 +452% 01 Jan 2021 31 Mar 2021 10-Q 26 Apr 2022 2022 Q1
Q4 2020 $152,906,000 $41,806,000 -$6,077,000 -13% 01 Oct 2020 31 Dec 2020 10-K 21 Feb 2023 2021 FY
Q3 2020 $158,983,000 $41,500,000 +$17,200,000 +71% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $141,783,000 $40,000,000 +$19,900,000 +99% 01 Apr 2020 30 Jun 2020 10-Q 28 Jul 2021 2021 Q2
Q1 2020 $121,883,000 $29,600,000 +$13,400,000 +83% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $108,483,000 $47,883,000 +$32,219,000 +206% 01 Oct 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
Q3 2019 $76,264,000 $24,300,000 +$7,800,000 +47% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020 2020 Q3
Q2 2019 $68,464,000 $20,100,000 +$4,500,000 +29% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $63,964,000 $16,200,000 +$3,700,000 +30% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $60,264,000 $15,664,000 +$3,152,000 +25% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
Q3 2018 $57,112,000 $16,500,000 +$5,700,000 +53% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019 2019 Q3
Q2 2018 $51,412,000 $15,600,000 +$9,500,000 +156% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019 2019 Q2
Q1 2018 $41,912,000 $12,500,000 +$6,400,000 +105% 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019 2019 Q1
Q4 2017 $35,512,000 $12,512,000 +$5,580,000 +80% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
Q3 2017 $29,932,000 $10,800,000 +$4,600,000 +74% 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018 2018 Q3
Q2 2017 $25,332,000 $6,100,000 +$1,600,000 +36% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q2
Q1 2017 $23,732,000 $6,100,000 $0 0% 01 Jan 2017 31 Mar 2017 10-Q 26 Apr 2018 2018 Q1
Q4 2016 $23,732,000 $6,932,000 +$1,982,000 +40% 01 Oct 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
Q3 2016 $21,750,000 $6,200,000 +$1,300,000 +27% 01 Jul 2016 30 Sep 2016 10-Q 30 Oct 2017 2017 Q3
Q2 2016 $20,450,000 $4,500,000 -$100,000 -2.2% 01 Apr 2016 30 Jun 2016 10-Q 25 Jul 2017 2017 Q2
Q1 2016 $20,550,000 $6,100,000 +$2,500,000 +69% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 $18,050,000 $4,950,000 +$2,030,000 +70% 01 Oct 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
Q3 2015 $16,020,000 $4,900,000 +$800,000 +20% 01 Jul 2015 30 Sep 2015 10-Q 26 Oct 2016 2016 Q3
Q2 2015 $15,220,000 $4,600,000 +$2,100,000 +84% 01 Apr 2015 30 Jun 2015 10-Q 26 Jul 2016 2016 Q2
Q1 2015 $13,120,000 $3,600,000 +$1,600,000 +80% 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016 2016 Q1
Q4 2014 $11,520,000 $2,920,000 +$776,000 +36% 01 Oct 2014 31 Dec 2014 10-K 21 Feb 2017 2016 FY
Q3 2014 $10,744,000 $4,100,000 +$2,300,000 +128% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015 2015 Q3
Q2 2014 $8,444,000 $2,500,000 -$300,000 -11% 01 Apr 2014 30 Jun 2014 10-Q 31 Jul 2015 2015 Q2
Q1 2014 $8,744,000 $2,000,000 +$1,000,000 +100% 01 Jan 2014 31 Mar 2014 10-Q 04 May 2015 2015 Q1
Q4 2013 $7,744,000 $2,144,000 01 Oct 2013 31 Dec 2013 10-K 24 Feb 2016 2015 FY
Q3 2013 $1,800,000 +$300,000 +20% 01 Jul 2013 30 Sep 2013 10-Q 31 Oct 2014 2014 Q3
Q2 2013 $2,800,000 +$1,300,000 +87% 01 Apr 2013 30 Jun 2013 10-Q 01 Aug 2014 2014 Q2
Q1 2013 $1,000,000 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014 2014 Q1
Q3 2012 $1,500,000 +$300,000 +25% 01 Jul 2012 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 $1,500,000 +$600,000 +67% 01 Apr 2012 30 Jun 2012 10-Q 26 Jul 2012 2012 Q2
Q3 2011 $1,200,000 01 Jul 2011 30 Sep 2011 10-Q 02 Nov 2012 2012 Q3
Q2 2011 $900,000 01 Apr 2011 30 Jun 2011 10-Q 26 Jul 2012 2012 Q2

EXACT SCIENCES CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $214,885,000 -$16,427,000 -7.1% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2025 2024 FY
2023 $231,312,000 +$24,489,000 +12% 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2025 2024 FY
2022 $206,823,000 -$132,403,000 -39% 01 Jan 2022 31 Dec 2022 10-K 19 Feb 2025 2024 FY
2021 $339,226,000 +$186,320,000 +122% 01 Jan 2021 31 Dec 2021 10-K 21 Feb 2024 2023 FY
2020 $152,906,000 +$44,423,000 +41% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2021 FY
2019 $108,483,000 +$48,219,000 +80% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
2018 $60,264,000 +$24,752,000 +70% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY
2017 $35,512,000 +$11,780,000 +50% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
2016 $23,732,000 +$5,682,000 +31% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
2015 $18,050,000 +$6,530,000 +57% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
2014 $11,520,000 +$3,776,000 +49% 01 Jan 2014 31 Dec 2014 10-K 21 Feb 2017 2016 FY
2013 $7,744,000 +$2,251,000 +41% 01 Jan 2013 31 Dec 2013 10-K 24 Feb 2016 2015 FY
2012 $5,493,000 +$1,493,000 +37% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $4,000,000 +$1,900,000 +90% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
2010 $2,100,000 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.